Read over every page. As optimistic as ever. CitiGroup has taken a nearly 10% stake since last report. All 3 Phase 2 trials in ASH, PNAFLD, and C.Diff. reading out in early 2019. Arun Sanyal believes in the company and IMM-124E for liver disease inflammation. The compound has broad therapeutic effect across so many GI diseases, liver disease, colitis, IBD, C.Diff, Shigella, ETEC, you nam
e it. Take a look at the preclinical C.Diff. results. They are incredible. Best I have ever seen to be honest. So excited about that readout. Potential value of company: C.Diff = $300M, Shigella = $200M, liver disease therapeutics = $500M to $1B, IBD = $300-$500M. Trades at $35M USD market cap. This ride is going to be so much fun
- Forums
- ASX - By Stock
- Thoughts on Annual Report
Read over every page. As optimistic as ever. CitiGroup has taken...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
9.3¢ |
Change
-0.005(5.10%) |
Mkt cap ! $21.20M |
Open | High | Low | Value | Volume |
9.6¢ | 9.6¢ | 9.2¢ | $21.53K | 230.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8315 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 21576 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8315 | 0.093 |
3 | 30988 | 0.091 |
1 | 500000 | 0.090 |
2 | 111235 | 0.089 |
3 | 95464 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 21576 | 1 |
0.105 | 295769 | 3 |
0.110 | 121204 | 4 |
0.115 | 50000 | 1 |
0.120 | 138000 | 3 |
Last trade - 12.53pm 05/09/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |